Literature DB >> 12832474

Normal reproductive function in InhBP/p120-deficient mice.

Daniel J Bernard1, Kathleen H Burns, Bisong Haupt, Martin M Matzuk, Teresa K Woodruff.   

Abstract

The inhibins are gonadal transforming growth factor beta superfamily protein hormones that suppress pituitary follicle-stimulating hormone (FSH) synthesis. Recently, betaglycan and inhibin binding protein (InhBP/p120, also known as the product of immunoglobulin superfamily gene 1 [IGSF1]) were identified as candidate inhibin coreceptors, shedding light on the molecular basis of how inhibins may affect target cells. Activins, which are structurally related to the inhibins, act within the pituitary to stimulate FSH production. Betaglycan increases the affinity of inhibins for the activin type IIA (ACVR2) receptor, thereby blocking activin binding and signaling through this receptor. InhBP/p120 may not directly bind inhibins but may interact with the activin type IB receptor, ALK4, and participate in inhibin B's antagonism of activin signaling. To better understand the in vivo functions of InhBP/p120, we characterized the InhBP/p120 mRNAs and gene in mice and generated InhBP/p120 mutant mice by gene targeting in embryonic stem cells. InhBP/p120 mutant male and female mice were viable and fertile. Moreover, they showed no alterations in FSH synthesis or secretion or in ovarian or testicular function. These data contribute to a growing body of evidence indicating that InhBP/p120 does not play an essential role in inhibin biology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832474      PMCID: PMC162213          DOI: 10.1128/MCB.23.14.4882-4891.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

Review 1.  Is the action of inhibin mediated via a unique receptor?

Authors:  D M Robertson; R Hertan; P G Farnworth
Journal:  Rev Reprod       Date:  2000-09

Review 2.  Roles of inhibins, activins, and follistatin in the female reproductive system.

Authors:  P G Knight
Journal:  Front Neuroendocrinol       Date:  1996-10       Impact factor: 8.606

Review 3.  Hope, hypothesis, and the inhibin receptor. Does specific inhibin binding suggest there is a specific inhibin receptor?

Authors:  T K Woodruff
Journal:  Endocrinology       Date:  1999-01       Impact factor: 4.736

4.  Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.

Authors:  J J Lebrun; W W Vale
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 5.  Inhibins, activins, and follistatins: the saga continues.

Authors:  L V DePaolo
Journal:  Proc Soc Exp Biol Med       Date:  1997-04

6.  Formation and activation by phosphorylation of activin receptor complexes.

Authors:  S A Willis; C M Zimmerman; L I Li; L S Mathews
Journal:  Mol Endocrinol       Date:  1996-04

7.  Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.

Authors:  K A Lewis; P C Gray; A L Blount; L A MacConell; E Wiater; L M Bilezikjian; W Vale
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

8.  Structure and expression of a membrane component of the inhibin receptor system.

Authors:  H Chong; S A Pangas; D J Bernard; E Wang; J Gitch; W Chen; L B Draper; E T Cox; T K Woodruff
Journal:  Endocrinology       Date:  2000-07       Impact factor: 4.736

9.  Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.

Authors:  T R Kumar; Y Wang; N Lu; M M Matzuk
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

10.  Reproductive defects in gamma-glutamyl transpeptidase-deficient mice.

Authors:  T R Kumar; A L Wiseman; G Kala; S V Kala; M M Matzuk; M W Lieberman
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

View more
  16 in total

Review 1.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

2.  TRH Action Is Impaired in Pituitaries of Male IGSF1-Deficient Mice.

Authors:  Marc-Olivier Turgeon; Tanya L Silander; Denica Doycheva; Xiao-Hui Liao; Marc Rigden; Luisina Ongaro; Xiang Zhou; Sjoerd D Joustra; Jan M Wit; Mike G Wade; Heike Heuer; Samuel Refetoff; Daniel J Bernard
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

3.  IGSF1 Deficiency Leads to Reduced TSH Production Independent of Alterations in Thyroid Hormone Action in Male Mice.

Authors:  Emilie Brûlé; Tanya L Silander; Ying Wang; Xiang Zhou; Beata Bak; Stefan Groeneweg; Daniel J Bernard
Journal:  Endocrinology       Date:  2022-08-01       Impact factor: 5.051

4.  The extant immunoglobulin superfamily, member 1 gene results from an ancestral gene duplication in eutherian mammals.

Authors:  Courtney L Smith; Paul M Harrison; Daniel J Bernard
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

5.  An internal signal sequence directs intramembrane proteolysis of a cellular immunoglobulin domain protein.

Authors:  Thalia Robakis; Beata Bak; Shu-huei Lin; Daniel J Bernard; Peter Scheiffele
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

Review 6.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

7.  The Hectd1 ubiquitin ligase is required for development of the head mesenchyme and neural tube closure.

Authors:  Irene E Zohn; Kathryn V Anderson; Lee Niswander
Journal:  Dev Biol       Date:  2007-03-20       Impact factor: 3.582

8.  Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement.

Authors:  Yu Sun; Beata Bak; Nadia Schoenmakers; A S Paul van Trotsenburg; Wilma Oostdijk; Peter Voshol; Emma Cambridge; Jacqueline K White; Paul le Tissier; S Neda Mousavy Gharavy; Juan P Martinez-Barbera; Wilhelmina H Stokvis-Brantsma; Thomas Vulsma; Marlies J Kempers; Luca Persani; Irene Campi; Marco Bonomi; Paolo Beck-Peccoz; Hongdong Zhu; Timothy M E Davis; Anita C S Hokken-Koelega; Daria Gorbenko Del Blanco; Jayanti J Rangasami; Claudia A L Ruivenkamp; Jeroen F J Laros; Marjolein Kriek; Sarina G Kant; Cathy A J Bosch; Nienke R Biermasz; Natasha M Appelman-Dijkstra; Eleonora P Corssmit; Guido C J Hovens; Alberto M Pereira; Johan T den Dunnen; Michael G Wade; Martijn H Breuning; Raoul C Hennekam; Krishna Chatterjee; Mehul T Dattani; Jan M Wit; Daniel J Bernard
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

9.  IGSF1 deficiency syndrome: A newly uncovered endocrinopathy.

Authors:  Sjoerd D Joustra; A S Paul van Trotsenburg; Yu Sun; Monique Losekoot; Daniel J Bernard; Nienke R Biermasz; Wilma Oostdijk; Jan M Wit
Journal:  Rare Dis       Date:  2013-05-02

Review 10.  Recent advances in central congenital hypothyroidism.

Authors:  Nadia Schoenmakers; Kyriaki S Alatzoglou; V Krishna Chatterjee; Mehul T Dattani
Journal:  J Endocrinol       Date:  2015-09-28       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.